Advertisement
Journal of Investigative Dermatology Home

Defining Psoriasis Remission Based on Histopathological and Molecular Criteria: A Systematic Literature Review

Published:November 24, 2021DOI:https://doi.org/10.1016/j.jid.2021.09.039
      Dear Editor,

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Society Members (SID/ESDR), remember to log in for access.
      Subscribe to Journal of Investigative Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Chamian F.
        • Lowes M.A.
        • Lin S.L.
        • Lee E.
        • Kikuchi T.
        • Gilleaudeau P.
        • et al.
        Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.
        Proc Natl Acad Sci U S A. 2005; 102: 2075-2080
        • Clark R.A.
        Gone but not forgotten: lesional memory in psoriatic skin.
        J Invest Dermatol. 2011; 131: 283-285
        • Gottlieb A.B.
        • Chamian F.
        • Masud S.
        • Cardinale I.
        • Abello M.W.
        • Lowes M.A.
        • et al.
        TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
        J Immunol. 2005; 175: 2721-2729
        • Haider A.S.
        • Lowes M.A.
        • Suarez-Farinas M.
        • Zaba L.C.
        • Cardinale I.
        • Khatcherian A.
        • et al.
        Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.
        J Immunol. 2008; 180: 1913-1920
        • Hawkes J.E.
        • Yan B.Y.
        • Chan T.C.
        • Krueger J.G.
        Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
        J Immunol. 2018; 201: 1605-1613
        • Johnson-Huang L.M.
        • Suarez-Farinas M.
        • Sullivan-Whalen M.
        • Gilleaudeau P.
        • Krueger J.G.
        • Lowes M.A.
        Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.
        J Invest Dermatol. 2010; 130: 2654-2663
        • Koo J.
        • Lebwohl M.
        Duration of remission of psoriasis therapies.
        J Am Acad Dermatol. 1999; 41: 51-59
        • Krueger J.G.
        • Fretzin S.
        • Suarez-Farinas M.
        • Haslett P.A.
        • Phipps K.M.
        • Cameron G.S.
        • et al.
        IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.
        J Allergy Clin Immunol. 2012; 130: 145-154 e9
        • Krueger J.G.
        • Wharton Jr., K.A.
        • Schlitt T.
        • Suprun M.
        • Torene R.I.
        • Jiang X.
        • et al.
        IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.
        J Allergy Clin Immunol. 2019; 144: 750-763
        • Reid C.
        • Griffiths C.E.M.
        Psoriasis and Treatment: Past, Present and Future Aspects.
        Acta Derm Venereol. 2020; 100adv00032
        • Russell C.B.
        • Rand H.
        • Bigler J.
        • Kerkof K.
        • Timour M.
        • Bautista E.
        • et al.
        Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.
        J Immunol. 2014; 192: 3828-3836
        • Suarez-Farinas M.
        • Fuentes-Duculan J.
        • Lowes M.A.
        • Krueger J.G.
        Resolved psoriasis lesions retain expression of a subset of disease-related genes.
        J Invest Dermatol. 2011; 131: 391-400
        • Tomalin L.E.
        • Russell C.B.
        • Garcet S.
        • Ewald D.A.
        • Klekotka P.
        • Nirula A.
        • et al.
        Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis.
        J Allergy Clin Immunol. 2020; 145: 922-932
        • Zaba L.C.
        • Cardinale I.
        • Gilleaudeau P.
        • Sullivan-Whalen M.
        • Suarez-Farinas M.
        • Fuentes-Duculan J.
        • et al.
        Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.
        J Exp Med. 2007; 204: 3183-3194